University of California San Francisco
Give to UCSF
<p>Francis Collins, director of the National Institutes of Health (NIH), describes the scientific goals and functions of the National Center for Advancing Translational Sciences (NCATS), a proposed new entity of the NIH that will strive to reengineer the process of developing drugs, diagnostics, and devices. </p>
<p>UCSF cognitive neuroscientist Adam Gazzaley has used functional brain imaging and EEG studies to discover that older adults fare worse than younger adults at remembering following distractions. He hopes to improve their performance with cognitive training, using a newly developed video game.</p>
<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>
<p>Scientists are making great strides in figuring out how the human brain develops, which are leading to novel ideas about the causes of a range of brain disorders, and are raising hopes for the regeneration of tissue that is lost in diseases such as Alzheimer’s. </p>
Five basic scientists at UCSF will be awarded the distinction of fellows by the American Association for the Advancement of Science (AAAS) on February 19.
Susan Hyde, an award-winning professor and scientist with the UCSF School of Dentistry, promotes practices that preserve oral health and quality of life for both patients and practitioners.
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
Stefan Habelitz, an engineer and materials scientist, is blazing a new research trail by investigating tooth enamel in the UCSF School of Dentistry's Marshall Lab, where researchers fruitfully focus on every facet of teeth, knowing they’re nothing to take for granted…
UCSF has hired two senior managers to strengthen the University’s research enterprise.
Larissa Podust, PhD, is working on a new drug for Chagas disease, a neglected scourge.
Researchers, who are interested in taking their research from the bench to the bedside, are encouraged to apply for a catalyst award by March 1.